Literature DB >> 34581464

Rest Tremor Pattern Predicts DaTscan (123 I-Ioflupane) Result in Tremulous Disorders.

Andrea Quattrone1, Rita Nisticò2, Maurizio Morelli1, Gennarina Arabia1, Marianna Crasà3, Basilio Vescio4, Alessandro Mechelli1, Giuseppe L Cascini5, Aldo Quattrone2,3.   

Abstract

Entities:  

Keywords:  DaTscan; Parkinson's disease; clinical practice; rest tremor; tremor pattern

Mesh:

Substances:

Year:  2021        PMID: 34581464      PMCID: PMC9293449          DOI: 10.1002/mds.28797

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   9.698


× No keyword cloud information.
Rest tremor (RT) is typical of Parkinson's disease (PD) but can occur in other tremulous disorders, such as essential tremor (ET) plus dystonic tremor, drug‐induced tremor, ET‐PD syndrome, and scans without evidence of dopaminergic deficit (SWEDD). Differentiating RT disorders clinically may be challenging and often requires DaTscan (123I‐ioflupane),2, 3 an expensive and time‐consuming procedure not widely available and rarely used in routine diagnosis of tremulous disorders. Thus, there is an urgent need for new reliable and cost‐effective biomarkers to reveal striatal dopaminergic deficit in tremulous patients in the absence of DaTscan. A few studies investigated the electrophysiological features of RT, suggesting the possible usefulness of tremor pattern for differentiating PD from other tremulous disorders.4, 5, 6, 7 These studies, however, were conducted in small patient series and focused on differentiation between the diseases rather than on the association between tremor pattern and DaTscan. In our study, we enrolled 205 consecutive patients with RT and assessed the performance of tremor features (pattern, frequency, amplitude, burst duration, coherence) in differentiating patients with abnormal DaTscan (DaT+) from those with normal DaTscan (DaT−) (see Methods in Supporting Information Appendix S1). A total of 123 patients with RT had DaT+, while 82 patients had DaT−. Clinical characteristics of these patients with RT are shown in Supporting Information Table S1. The pattern (alternating or synchronous, Fig. 1A) was the RT feature that performed the best in distinguishing patients with striatal dopaminergic deficit from those with integrity of striatal dopaminergic neurons (Fig. 1B,C; Supporting Information Table S2). Random Forest feature selection and multivariate logistic regression model did not significantly improve the classification of DaT+ and DaT− patients compared with using RT pattern alone (Fig. 1D), suggesting that this tremor feature, which balances simplicity and accuracy, may represent the best option in clinical practice. RT pattern and DaTscan were strongly associated with each other, supporting the usefulness of pattern for predicting DaTscan result (odds pattern DaT−/synchronous, 3.74; odds pattern DaT+/alternating, 9.45; odds ratio, 34.3; confidence interval, 14.9–86.1). In our cohort, the large majority (104/115, 90.4%) of alternating patients were DaT+, while 71/90 (78.9%) synchronous patients were DaT−. Eighty‐five of 104 (81.7%) alternating DaT+ patients had parkinsonian tremor, while all DaT− synchronous patients were affected by non‐parkinsonian RT disorders (Supporting Information Table S3). Our study has several strengths. First, we demonstrated the stability of RT pattern both in the short‐ and long‐term periods (Supporting Information Results), which is necessary to use this biomarker in the diagnosis of tremulous syndromes. Second, patients were prospectively followed for 2 years to confirm clinical diagnosis. Third, the use of RT pattern for predicting DaTscan result can translate into economic advantages by reducing the need for expensive procedures for correct tremor diagnosis. A limitation to this study is that it was performed in a large cohort from a single center, and further validation in an independent international cohort is warranted.
FIG. 1

(A) Electromyographic recordings from the extensor carpi radialis and flexor carpi ulnaris muscles of a patient with alternating pattern and a patient with synchronous pattern of rest tremor (RT). (B) Receiving operating characteristic (ROC) curves for assessing the classification performance of RT pattern (red) (area under the curve [AUC], 0.86; 95% confidence interval [CI], 0.81–0.91), amplitude (green) (AUC, 0.77; 95% CI, 0.69–0.84), frequency (blue) (AUC, 0.70; 95% CI, 0.62–0.78), burst duration (gray) (AUC, 0.54; 95% CI, 0.46–0.62), and coherence (black) (AUC, 0.49; 95% CI, 0.38–0.59) in differentiating patients with RT with abnormal DaTscan (DaT+) from those with normal DaTscan (DaT−). (C) ROC curves for assessing the classification performance of RT pattern (red) (AUC, 0.86; 95% CI, 0.81–0.91) and bradykinesia score (blue) (AUC, 0.68; 95% CI, 0.61–0.75) in differentiating patients with RT with DaT+ from those with DaT−. The bradykinesia score was calculated as the mean of the scores of the Unified Parkinsonʼs Disease Rating Scale motor, Part III items 23 (finger tapping), 24 (hand movements), and 25 (pronation‐supination movements) in the most affected upper limb with RT. (D) ROC curves for assessing the classification performance of RT pattern (red) (AUC, 0.86; 95% CI, 0.81–0.91) and multivariate logistic regression model with Random Forest feature selection (blue) (AUC, 0.90; 95% CI, 0.84–0.95) in differentiating patients with RT with DaT+ from those with DaT−. The performances of both classifiers are compared using DeLong's test (P = 0.27). The variables selected using Random Forest were pattern (importance = 5.61), amplitude (importance = 4.83), frequency (importance = 4.07), and burst duration (importance = 3.14). The cohort included 123 DaT+ and 82 DaT− patients. [Color figure can be viewed at wileyonlinelibrary.com]

(A) Electromyographic recordings from the extensor carpi radialis and flexor carpi ulnaris muscles of a patient with alternating pattern and a patient with synchronous pattern of rest tremor (RT). (B) Receiving operating characteristic (ROC) curves for assessing the classification performance of RT pattern (red) (area under the curve [AUC], 0.86; 95% confidence interval [CI], 0.81–0.91), amplitude (green) (AUC, 0.77; 95% CI, 0.69–0.84), frequency (blue) (AUC, 0.70; 95% CI, 0.62–0.78), burst duration (gray) (AUC, 0.54; 95% CI, 0.46–0.62), and coherence (black) (AUC, 0.49; 95% CI, 0.38–0.59) in differentiating patients with RT with abnormal DaTscan (DaT+) from those with normal DaTscan (DaT−). (C) ROC curves for assessing the classification performance of RT pattern (red) (AUC, 0.86; 95% CI, 0.81–0.91) and bradykinesia score (blue) (AUC, 0.68; 95% CI, 0.61–0.75) in differentiating patients with RT with DaT+ from those with DaT−. The bradykinesia score was calculated as the mean of the scores of the Unified Parkinsonʼs Disease Rating Scale motor, Part III items 23 (finger tapping), 24 (hand movements), and 25 (pronation‐supination movements) in the most affected upper limb with RT. (D) ROC curves for assessing the classification performance of RT pattern (red) (AUC, 0.86; 95% CI, 0.81–0.91) and multivariate logistic regression model with Random Forest feature selection (blue) (AUC, 0.90; 95% CI, 0.84–0.95) in differentiating patients with RT with DaT+ from those with DaT−. The performances of both classifiers are compared using DeLong's test (P = 0.27). The variables selected using Random Forest were pattern (importance = 5.61), amplitude (importance = 4.83), frequency (importance = 4.07), and burst duration (importance = 3.14). The cohort included 123 DaT+ and 82 DaT− patients. [Color figure can be viewed at wileyonlinelibrary.com] The alternating pattern of RT is a powerful, low‐cost, and widely available biomarker of striatal dopaminergic deficit in tremulous patients. The evaluation of tremor pattern could help clinicians distinguish parkinsonian RT associated with dopaminergic deficit from non‐parkinsonian RT with intact dopaminergic neurons and guide the decision making in clinical practice.

Author Roles

1. Research project: A. Conception, B. Organization, C. Execution; 2. Statistical analysis: A. Design, B. Execution, C. Review and Critique; 3. Manuscript: A. Writing of the first draft, B. Review and Critique. Andrea Quattrone: 1A, 1B, 1C, 3A, 3B Rita Nisticò: 1B, 1C Maurizio Morelli: 1B, 1C Gennarina Arabia: 1B, 1C Marianna Crasà: 1B, 1C Basilio Vescio: 2A, 2B, 2C Alessandro Mechelli: 1B, 1C Giuseppe L. Cascini: 1B, 1C Aldo Quattrone: 1A, 1B, 3B

Full Financial Disclosures for the Previous 12 Months

The authors received no funding from any institution, including personal relationships, interests, grants, employment, affiliations, patents, inventions, honoraria, consultancies, royalties, stock options/ownership, or expert testimony for the last 12 months. Table S1. Demographic, clinical, electrophysiological and imaging data of patients with rest tremor Click here for additional data file. Table S2. Diagnostic performance of tremor electrophysiological features in distinguishing rest tremor patients with striatal dopaminergic deficit from those with normal DaTscan. Click here for additional data file. Table S3. Clinical diagnoses of patients with alternating or synchronous rest tremor pattern at the two‐year follow‐up. Click here for additional data file. Appendix S1. Supporting Information Click here for additional data file.
  7 in total

1.  Synchronous pattern distinguishes resting tremor associated with essential tremor from rest tremor of Parkinson's disease.

Authors:  R Nisticò; D Pirritano; M Salsone; F Novellino; F Del Giudice; M Morelli; M Trotta; G Bilotti; F Condino; A Cherubini; P Valentino; A Quattrone
Journal:  Parkinsonism Relat Disord       Date:  2010-11-10       Impact factor: 4.891

2.  Clinical, electrophysiological, and imaging study in essential tremor-Parkinson's disease syndrome.

Authors:  Gennarina Arabia; Angela Lupo; Lucia Ilaria Manfredini; Basilio Vescio; Rita Nisticò; Gaetano Barbagallo; Maria Salsone; Maurizio Morelli; Fabiana Novellino; Giuseppe Nicoletti; Andrea Quattrone; Giuseppe Lucio Cascini; Elan D Louis; Aldo Quattrone
Journal:  Parkinsonism Relat Disord       Date:  2018-06-05       Impact factor: 4.891

3.  Tremor pattern differentiates drug-induced resting tremor from Parkinson disease.

Authors:  R Nisticò; A Fratto; B Vescio; G Arabia; G Sciacca; M Morelli; A Labate; M Salsone; F Novellino; A Nicoletti; A Petralia; A Gambardella; M Zappia; A Quattrone
Journal:  Parkinsonism Relat Disord       Date:  2016-02-03       Impact factor: 4.891

4.  Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders.

Authors:  Vicky Marshall; Donald G Grosset
Journal:  Mov Disord       Date:  2003-10       Impact factor: 10.338

Review 5.  Systematic clinical approach for diagnosing upper limb tremor.

Authors:  Jaron van de Wardt; A M Madelein van der Stouwe; Michiel Dirkx; Jan Willem J Elting; Bart Post; Marina Aj Tijssen; Rick C Helmich
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-05-26       Impact factor: 10.154

Review 6.  Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes.

Authors:  Nin Bajaj; Robert A Hauser; Igor D Grachev
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-03-13       Impact factor: 10.154

7.  Differential Diagnosis of Parkinson Disease, Essential Tremor, and Enhanced Physiological Tremor with the Tremor Analysis of EMG.

Authors:  Jie Zhang; Yan Xing; Xiuli Ma; Liqun Feng
Journal:  Parkinsons Dis       Date:  2017-08-14
  7 in total
  2 in total

1.  Evaluation of rest tremor in different positions in Parkinson's disease and essential tremor plus.

Authors:  Rita Nisticò; Andrea Quattrone; Marianna Crasà; Marida De Maria; Basilio Vescio; Aldo Quattrone
Journal:  Neurol Sci       Date:  2022-01-15       Impact factor: 3.307

2.  Cerebellar voxel-based morphometry in essential tremor.

Authors:  Alessia Sarica; Andrea Quattrone; Marianna Crasà; Rita Nisticò; Maria Grazia Vaccaro; Maria Giovanna Bianco; Vera Gramigna; Marida De Maria; Basilio Vescio; Federico Rocca; Aldo Quattrone
Journal:  J Neurol       Date:  2022-07-19       Impact factor: 6.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.